Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-441-AG21 | 29-12-2021 | Farmaceutica Insuval S.A. | Recepcion Conforme | $714.000 |
| 2980-442-AG21 | 29-12-2021 | Comercializadora Lpc Chile SpA | Recepcion Conforme | $571.200 |
| 2980-439-SE21 | 27-12-2021 | Andes Solutions | Recepcion Conforme | $599.522 |
| 2980-436-SE21 | 22-12-2021 | Astrazeneca S.A. | Recepcion Conforme | $5.036.281 |
| 2980-437-SE21 | 21-12-2021 | Reutter Limitada | Recepcion Conforme | $910.350 |
| 2980-427-AG21 | 21-12-2021 | Comercial Red Office Limitada | Recepcion Conforme | $303.402 |
| 2980-438-AG21 | 21-12-2021 | Proveedores Integrales Prisa S.A. | Recepcion Conforme | $489.176 |
| 2980-428-SE21 | 15-12-2021 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $1.167.580 |
| 2980-429-SE21 | 15-12-2021 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $3.582.566 |
| 2980-430-SE21 | 15-12-2021 | Abbott Laboratories de Chile Ltda. | Recepcion Conforme | $1.159.179 |
| 2980-431-SE21 | 15-12-2021 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | Recepcion Conforme | $4.057.019 |
| 2980-432-SE21 | 15-12-2021 | Laboratorio Biotoscana Farma SpA | Recepcion Conforme | $2.918.118 |
| 2980-433-SE21 | 15-12-2021 | Gador Limitada | Recepcion Conforme | $3.186.868 |
| 2980-435-SE21 | 15-12-2021 | Mg Proveedores Industriales Limitada | Recepcion Conforme | $6.625.920 |
| 2980-423-SE21 | 14-12-2021 | Auditron Chile S.A. | Recepcion Conforme | $9.091.600 |
| 2980-434-SE21 | 14-12-2021 | Novartis Chile S.A. | Recepcion Conforme | $4.726.190 |
| 2980-417-AG21 | 13-12-2021 | Allmedica Sociedad Anonima | Recepcion Conforme | $261.800 |
| 2980-418-AG21 | 13-12-2021 | Comercial The Magic Limitada | Recepcion Conforme | $171.934 |
| 2980-420-AG21 | 13-12-2021 | Comercial The Magic Limitada | Recepcion Conforme | $113.050 |
| 2980-421-AG21 | 13-12-2021 | Dia & Tec Import Exportad y Distrib de Sistemas Diagnosticos y Tec Ltd | Recepcion Conforme | $130.305 |
| 2980-425-CM21 | 13-12-2021 | Inversiones Tecnologicas Rsb SpA | Recepcion Conforme | $13.023.360 |
| 2980-426-SE21 | 13-12-2021 | Gador Limitada | Recepcion Conforme | $4.326.840 |
| 2980-422-SE21 | 06-12-2021 | Novartis Chile S.A. | Recepcion Conforme | $2.768.821 |
| 2980-424-AG21 | 03-12-2021 | Comercializadora Lpc Chile SpA | Recepcion Conforme | $464.100 |
| 2980-397-CM21 | 02-12-2021 | Hospital & Medical Solutions S.A. | Recepcion Conforme | $234.430 |
| 2980-401-AG21 | 02-12-2021 | Proveedores Integrales Prisa S.A. | Recepcion Conforme | $262.841 |
| 2980-404-AG21 | 02-12-2021 | Comercial Roian Store SpA | Recepcion Conforme | $289.170 |
| 2980-406-SE21 | 02-12-2021 | Novofarma Service S.A. | Recepcion Conforme | $2.127.125 |
| 2980-408-SE21 | 02-12-2021 | Novofarma Service S.A. | Recepcion Conforme | $4.440.742 |
| 2980-409-SE21 | 02-12-2021 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | Recepcion Conforme | $1.014.237 |
